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Postherpetic neuralgia (PHN) is a common and exceptionally drug-resistant neuropathic
pain condition. In this cross-sectional skin biopsy study, seeking information on the
responsible pathophysiological mechanisms we assessed how ophthalmic PHN affects
sensory and autonomic skin innervation. We took 2-mm supraorbital punch skin biopsies
from the affected and unaffected sides in 10 patients with ophthalmic PHN. Using indirect
immunofluorescence and a large panel of antibodies including protein gene product
(PGP) 9.5 we quantified epidermal unmyelinated, dermal myelinated and autonomic
nerve fibers. Although skin biopsy showed reduced epidermal and dermal myelinated
fiber density in specimens from the affected side, the epidermal/dermal myelinated
nerve fiber ratio was lower in the affected than in the unaffected side (p < 0.001),
thus suggesting a predominant epidermal unmyelinated nerve fiber loss. Conversely,
autonomic skin innervation was spared. Our study showing that ophthalmic PHN
predominantly affects unmyelinated nerve fiber and spares autonomic nerve fiber might
help to understand the pathophysiological mechanisms underlying this difficult-to-treat
condition.
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Introduction
Ophthalmic postherpetic neuralgia (PHN) is a disabling and extensively investigated neuropathic
pain condition caused by herpes zoster and persisting or recurring for at least 3 months in areas
supplied by the ophthalmic division of the trigeminal nerve (IHS Classification, 2013).1
Studies assessing cutaneous innervation in skin biopsy specimens have provided new insight
into themechanisms underlying neuropathic pain in several conditions (Sommer and Lauria, 2007).
Skin biopsy is a minimally invasive diagnostic tool used to assess nerve fiber in the human epidermis
1http://www.ihs-classification.org/_downloads/mixed/International-Headache-Classification-III-ICHD-III-2013-
Beta.pdf
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and dermis. Epidermal innervation consists mainly of
unmyelinated C-fiber terminals, with relatively few small
myelinated Aδ-fibers that lose their myelin sheath and reach
the epidermis as unmyelinated free nerve endings. Conversely,
dermal innervation consists mainly of large myelinated Aβ-
fibers that send branches to dermal corpuscles and hair follicles
(Nolano et al., 2003, 2013).
Most morphometric studies used bright-field
immunohistochemistry with protein gene product (PGP)
9.5 immunostaining and assessed epidermal innervation alone.
An approach based on immunofluorescence and confocal
microscopy using double and triple immunostaining with an
extensive panel of antibodies including the pan-neuronal marker
PGP 9.5, the basement membrane marker, collagen IV (ColIV),
and antibodies for various myelinated and unmyelinated nerve
fiber populations, has proved to provide distinct information
on sensory and autonomic nerve fibers, and possibly assess skin
innervation more accurately (Doppler et al., 2012; Nolano et al.,
2013).
Although previous skin biopsy studies have shown a severe
epidermal nerve fiber (ENF) loss in the affected thoracic
dermatomes of patients with PHN (Oaklander, 2001; Petersen
et al., 2010), they did not directly investigate ophthalmic PHN,
nor did they distinguish epidermal unmyelinated and dermal
myelinated fibers, or accurately detail autonomic nerve fiber
involvement. Having this information might more precisely
define the pathophysiological mechanisms underlying PHN,
thus possibly improving the way we diagnose and cure this
exceptionally drug-resistant neuropathic pain condition.
Continuing our research interest into the mechanisms
underlying neuropathic pain in peripheral nerve diseases (Truini
et al., 2014) including PHN (Truini et al., 2008), in this
clinical and morphometric study, we aimed at investigating how
ophthalmic PHN affects myelinated and unmyelinated sensory
and autonomic skin nerve fibers. To do so we took 2-mm
supraorbital punch skin biopsies from the affected side and
unaffected mirror side in ten patients with ophthalmic PHN. We
processed the skin specimens with indirect immunofluorescence,
examined the specimens by confocal microscopy, distinguished
epidermal unmyelinated and dermal myelinated innervation,
and described autonomic nerve fiber involvement.
Materials and Methods
We enrolled 10 patients (3 F, 7 M; 74.5 ± 4.4 years)
with ophthalmic PHN in the Department of Neurology,
Sapienza University, Rome. Ophthalmic PHN was diagnosed in
accordance with the International Headache Society diagnostic
criteria: pain persisting or recurring for at least 3 months in
the area supplied by the ophthalmic division of the trigeminal
nerve, and caused by herpes zoster. Exclusion criteria were
cognitive impairment, other central and peripheral nervous
system diseases. No patient was treated with topical pain
medications (i.e., lidocaine and capsaicin).
The Institutional Review Board of the Department of
Neurology, Policlinico Umberto I, Rome, approved the study and
patients gave their informed consent.
Clinical and Neurophysiological Assessment
All participants underwent a general examination and a
neurologic examination, with full sensory testing including
negative (tactile, pinprick, and thermal hypoesthesia) and
positive symptoms (ongoing spontaneous pain, paroxysmal
pain) and signs (mechanical dynamic allodynia, and pinprick
hyperalgesia). The presence and severity of negative symptoms
were assessed by comparing the affected side with the mirror
image on the healthy side. The severity of the different pain types
(i.e., ongoing spontaneous pain, paroxysmal pain, mechanical
dynamic allodynia, pinprick hyperalgesia) was rated on a 0–10
numeric rating scale (NRS; 0 = no sensation, 10 = worst possible
pain).
In all patients, we recorded the Aβ-myelinated fiber-mediated
blink reflex, with methods adhering to the recommendations
of the International Federation of Clinical Neurophysiology
guidelines (Deuschl and Eisen, 1999). To investigate Aδ and C
fiber function we recorded laser evoked potentials, according to
a previously reported technique (Truini et al., 2008).
Skin Biopsy
Two-mm punch skin biopsies were taken immediately above
the eyebrow from the affected and unaffected mirror side. The
wound healed in a few days without a visible scar (Figure 1). Skin
samples were processed with immunohistochemical techniques,
as previously described (Nolano et al., 2013). Specimens
were fixed overnight in Zamboni solution, cryoprotected in
20% sucrose in phosphate-buffered saline and cut into 50-
µm-thick sections on a freezing microtome (Leica 2000R,
Germany). Free-floating sections were processed for indirect
immunofluorescence using an antibody panel to stain sensory,
autonomic skin innervation and vascular structures, including
PGP9.5, calcitonin gene-related peptide (CGRP), substance
P (SubP) and vasoactive intestinal peptide (VIP) antibodies
(Table 1). Digital images were acquired using non-laser confocal
FIGURE 1 | Two-mm supraorbital punch skin biopsy. (A) Photograph of a
patient with postherpetic neuralgia (PHN) showing the 2-mm skin wound
immediately after the punch. (B) After 1 week, the scar is hardly visible.
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TABLE 1 | Abbreviation, source and dilution of immunohistochemical markers.
Marker Abbreviation Source Dilution Targeted structure
Rabbit anti protein gene product 9.5 r-PGP SpringBio 1:400 Pan-neuronal
Rabbit anti vasoactive intestinal peptide r-VIP Immunostar 1:1000 Cholinergic fibers
Mouse anti vasoactive intestinal peptide m-VIP Santa Cruz 1:300 Cholinergic fibers
Mouse anti protein gene product 9.5 m-PGP AbDSerotec 1:800 Pan-neuronal
Mouse anti collagen IV m-Col IV Chemicon 1:800 Basal membrane, vessels
Rabbit anti substance p r-Sub P Incstar 1:1000 Nociceptive fibers
Rabbit anti calcitonin gene related peptide r-CGRP Amersham 1:1000 Nociceptive fibers
Rabbit anti s100 r-s100 Maxim Biotech 1:10 Schwann cells
Mouse m-MBP Ultraclone 1:800 Myelinated fibers
Rabbit anti dopamine β hydroxilase r-DβH Chemicon 1:150 Noradrenergic fibers
ULEX europaeus agglutinin 1 ULEX Vector 1:100 Epithelia and endothelia
microscopy (CARV confocal system; ATTO Biosciences, USA
and Apotome confocal system; Zeiss, Germany).
ENF density was assessed in the 2-mm skin punch biopsy
samples by applying Neurolucida software (MicroBrightField
Bioscience, USA) to four 20× z-series confocal images (2 µm ×
16 increments), obtained from four randomly-selected sections
for each sample. Dermal myelinated nerve fibers were quantified
using anti-myelin basic protein antibodies in the entire dermal
surface including 1 mm in depth from the basement membrane
in three random sections for each sample, following previously
published procedure (Nolano et al., 2013). A calibrated grid (2×
1 mm) with a series of seven equidistant parallel lines was applied
on a digital non-confocal 5× original magnification image of
myelin basic protein-stained sections. All intercepts between
myelinated fibers and the grid lines were counted. Dermal
myelinated nerve fiber density was calculated as the number of
fibers intercepting the grid per dermal area (intercepts per mm2).
A single operator blindly quantified skin nerve fiber in each
sample. VIP-ir sudomotor nerve length density (nm/mm3) was
calculated using the nerve tracing module Autoneuron, a part
of Neurolucida software [Microbrightfield Bioscience (MBFB),
Williston, VT, USA], as previously described (Provitera et al.,
2014). To assess peptidergic fibers (SubP, CGRP and VIP-ir)
in the subepidermal neural plexus, within 100 µm from the
basement membrane, a semiquantitative scoring was applied
(0 = absence of fibers, 1 = rare fiber segments, shorter than 10
µm, 2 = few fibers, populating largely denervated dermis, 3 =
normal, several fibers covering most of the subepidermal neural
plexus).
Skin biopsy findings in the 10 patients were compared with
a matched sample of 10 healthy subjects (epidermal nerve fiber
density: 18.9 ± 3.7/mm, dermal myelinated fiber density: 6.7 ±
1.4/mm; Nolano et al., 2013).
Statistical Analysis
All data are expressed as mean ± SD. Normal distribution of
epidermal and dermal myelinated fiber density was evaluated
using D’Agostino and Pearson omnibus normality test.
The Wilcoxon matched-pair test was used for comparing
neurophysiological and skin biopsy variables between unaffected
and affected sides. The Mann Whitney test was used for
comparing skin biopsy variables between PHN patients and
normal controls. Correlations between the ENF density and
PHN duration were calculated with the Pearson’s r correlation
coefficient. P values less than or equal to 0.05 were considered to
indicate statistical significance.
Results
At clinical examination all ten patients complained of sensory
deficits involving all sensory modalities and reported ongoing
spontaneous pain (NRS: 4.3± 1.4); five patients also complained
of mechanical dynamic allodynia (NRS: 3.5± 0.7).
Neurophysiologic testing showed severe abnormalities
involving all variables tested. In all patients Aβ-fiber-mediated
blink reflex, stimulating the affected side, elicited abnormal
(delayed or absent) responses. Laser perceptive thresholds were
higher and Aδ- and C-laser evoked potential amplitudes lower
after stimulating the affected side than after stimulating the
unaffected side (p < 0.05, Wilcoxon test). In 2 of the 10 patients,
laser evoked potentials related to C-fiber stimulation were absent
also in the unaffected side (Table 2).
Confocal immunofluorescence analysis showed that skin
innervation in the supraorbital punch skin biopsies from
patients with PHN differed strikingly between the unaffected
(Figures 2A,C,E) and affected sides (Figures 2B,D,F). Whereas
skin biopsy samples from the unaffected side displayed a
fairly dense and regular innervation, the epidermis in the
affected side appeared poorly and unevenly innervated with
clusters and long tracts devoid of nerve fibers (Figures 2A–D).
Semiquantitative analysis showed that the subepidermal plexus
appeared poor and deranged and, compared to the unaffected
side, contained less (p < 0.001) CGRP (1.4 ± 0.8 vs.
2.5 ± 0.5), SubP (1.1 ± 0.6 vs. 2.3 ± 0.7), and VIP (1.0 ±
0.7 vs. 2.2 ± 0.8) immunoreactive (IR) nerve fibers. Hair
follicles appeared poorly innervated with few unmyelinated
and myelinated fibers (Figures 2F,E). Epidermal and dermal
myelinated fiber loss varied from moderate to severe and
3 of the 10 patients had complete skin denervation. The
few surviving epidermal axons were clustered between areas
of denervated epidermis. Myelinated fibers showed several
morphological abnormalities, such as fragmentation, frequent
occurrence of longer nodal length than normal (7 µm or longer;
Nolano et al., 2003), and caliber irregularities with enlargement
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TABLE 2 | Abbreviation, source and dilution of immunohistochemical markers.
Normal side (mean ± SD) Affected side (mean ± SD) p
R1 latency (ms) 11.3 ± 0.6 14.4 ± 1.4* 0.03
Pinprick laser perceptive threshold (mJ/mm2) 58.5 ± 12.1 101.6 ± 43.3 0.004
Warm laser perceptive threshold (mJ/mm2) 26.8 ± 10.9 53.20 ± 13.2 0.002
Aδ-fiber laser evoked potential amplitude (µV) 18.3 ± 4.9 6.1 ± 7.2** 0.006
C-fiber laser evoked potential amplitude (µV) 10.5 ± 8.6*** 3.1 ± 4.3**** 0.02
Epidermal nerve fiber density/mm 17.2 ± 8.9 3.1 ± 3.3 0.002
Myelinated dermal nerve fiber density/mm 6.6 ± 5.0 2.1 ± 2.8 0.004
Epidermal/dermal nerve fiber density ratio 4.3 ± 5.3 1.1 ± 1.0 0.006
*Absent in 4 patients; **absent in 5 patients; ***absent in 2 subjects; ****absent in 6 subjects.
FIGURE 2 | Skin innervation. Confocal images showing skin
innervation in the unaffected (A,C,E) and affected side (B,D,F) in a
representative patient with PHN. Severe epidermal and dermal nerve
fiber loss is visible in skin biopsy specimens from the affected side
(B vs. A). The epidermis in the affected side displays a long tract devoid
of nerve fibers and nerve fiber clusters (D vs. C). Striking unmyelinated
and myelinated nerve fiber loss around hair follicles (F vs. E). Bars: 100
µm in (A,B,E,F); 25 µm in (C,D).
and shrinkage (change in diameter over 100%) within the same
internode. These features were rarely observed in the unaffected
side. In contrast with sensory innervation, both components,
adrenergic and cholinergic, of autonomic innervation to the
dermal annexes appeared relatively preserved (Figure 3). The
unaffected and affected sides displayed numerous cholinergic
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FIGURE 3 | Autonomic skin innervation. Confocal images showing
Autonomic innervation to dermal annexes in the affected (A,C,E) and
unaffected side (B,D,F). The upper dermis around hair follicles in the
affected side contains fewer vasoactive intestinal peptide-immunoreactive
(VIP-IR) fibers than the same dermal area in the unaffected side (A vs. B)
whereas VIP-ir sudomotor and DbH-ir pilomotor innervation is well
endowed (D and F vs. C and E). Bars: 100 µm in (A,B); 50 µm in (C,D),
25 µm in (E,F).
(VIP-ir) sudomotor (Figures 3C,D) and adrenergic (DbH-ir)
pilomotor (Figures 3E,F) fibers. Cholinergic sudomotor nerve
fiber density did not differ between affected (1.9± 0.7 nm/mm3)
and unaffected side (2.0± 0.5 nm/mm3).
Quantitative analysis (based on analysis of PGP9.5 and
myelin basic protein (MBP) immunoreactivity) of the skin
biopsy samples showed a significantly lower epidermal and
dermal myelinated fiber density in the affected side than in the
unaffected side (3.1 ± 3.3 and 2.1 ± 2.8 vs. 17.2 ± 8.9 and 6.6
± 5.0/mm2; p < 0.01, Table 2). The ratio between epidermal
and dermal myelinated nerve fibers was significantly lower in
the affected than in the unaffected side (1.1 ± 1.0 vs. 4.3 ± 5.3;
p< 0.01).
Although the ENF density increased with the PHN duration,
this correlation failed to reach statistical significance (r: 0.5574,
p = 0.09; Figure 4).
The mean values for unmyelinated and myelinated nerve-
fiber densities in the unaffected side did not differ from controls
(epidermal nerve fiber density: 17.2 ± 8.9/mm vs. 18.9 ±
3.7/mm; dermal myelinated fiber density: 6.6 ± 5.0/mm vs.
6.7 ± 1.4/mm; p > 0.3, by Mann-Whitney test). However, in
the two patients with abnormal C-fiber-mediated laser evoked
potentials, skin biopsy showed an epidermal and a dermal
myelinated nerve fiber loss also in the unaffected side (0.8 and
3.6/mm in the unaffected and 0.0 and 0.3/mm in the affected
side).
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FIGURE 4 | Correlation between epidermal nerve fiber (ENF) density
and PHN duration. Although the ENF density increased with the PHN
duration, this correlation missed the statistical significance (epidermal nerve
fiber: r: 0.5574, p = 0.09).
Discussion
Our clinical and morphometric study, assessing skin
innervation in supraorbital punch skin biopsies with indirect
immunofluorescence and confocal microscopy, provides new
information specifying that although ophthalmic PHN affects
both epidermal unmyelinated and dermal myelinated nerve
fibers, it predominantly damages unmyelinated nerve fibers and
spares autonomic skin innervation.
Clinical examination showed that all patients had
tactile, pinprick, and warm hypoesthesia. Accordingly, all
the three neurophysiological variables we recorded (the
Aβ-fiber mediated blink reflex, Aδ- and C-laser evoked
potentials) were abnormal. Whereas clinical assessment
and neurophysiologic testing showed both myelinated
and unmyelinated fiber damage, skin biopsy assessment
specified that PHN-related damage to skin innervation
differed in myelinated and unmyelinated fibers. More
specifically, the lower unmyelinated/myelinated ratio in the
affected side than in the unaffected mirror side suggests a
predominant epidermal unmyelinated nerve fiber loss. This
new morphometric finding agrees with previous studies that
investigated epidermal innervation alone and, showed a variable
unmyelinated fiber loss (Oaklander, 2001; Petersen et al.,
2010; Reda et al., 2013). The predominant unmyelinated
nerve fiber involvement we describe in patients with PHN
fits in with their typically ongoing pain. This type of
pain probably reflects secondary neuroplastic changes and
spontaneous hyperactivity in the anatomically denervated
second-order nociceptive neurons (Truini et al., 2013).
Owing to the small study sample we could not reliably
investigate possible correlations between pain and clinical,
neurophysiological and morphological abnormalities. This
question deserves investigation in a further study enrolling more
patients.
In this skin biopsy study, using indirect immunofluorescence
and confocal microscopy, we provide previously unreported
detailed information on skin autonomic innervation in patients
with ophthalmic PHN. Whereas autonomic innervation to
sweat glands and to erector pilorum muscles was spared,
we observed a poor representation of VIP-IR fibers in the
upper dermis, around vessels and hair follicles, where there
was also a poor representation of CGRP and SubP. Some
of these fibers modulate hair follicle function and facial
vasomotor control, and may originate from the sensory
trigeminal nerve (Izumi, 1995, 1999). This origin may
explain their involvement in PHN whereas the uninvolved
sudomotor and pilomotor VIP-IR nerve fibers probably
originate from the superior cervical sympathetic ganglia
and from cranial parasympathetic nerves that PHN leaves
intact. Given that many studies suggest that the autonomic
nervous system might participate in the development of pain
(Fields et al., 1998), the autonomic nerve fiber sparing we
describe here might support the proposed indirect coupling
between intact sympathetic postganglionic and damaged
primary afferent unmyelinated neurons (Drummond et al.,
2014).
In our patients with ophthalmic PHN skin biopsy findings
showed that the few surviving axons in the affected side
were clustered between areas of denervated epidermis and
that ENF density tended to increase with disease duration.
This observation leads us to conjecture that the skin could
undergo some nerve remodeling over time. These changes
could take place when the surviving axons sprout collaterals
in an attempt to occupy the denervated territory. This
anatomical remodeling may also bring about some functional
improvement. Admittedly, our hypothesis suggesting a partial
reinnervation over time in patients with ophthalmic PHN
argues against pivotal studies addressing the natural history of
thoracic PHN (Petersen et al., 2010; Reda et al., 2013). These
studies using functional measures and skin biopsy conclude
that even at 7.7 years, there is only a modest recovery
of sensory function and no anatomic recovery despite pain
resolution in the majority of patients. In particular, the study
by Reda and colleagues showed that although pain and most
measures of sensory function, sensory symptoms, and capsaicin
response continued a trend toward improvement during a
long-term follow-up, many subjects still experienced sensory
abnormalities. Although we cannot exclude that the reliability
of our findings might be influenced by the small sample
of patients, whether the the trigeminal system, a peculiar
territory, is more predisposed to skin reinnervation than
other body areas remains an interesting question for future
research.
The mean epidermal and dermal myelinated fiber density
and their ratio in the unaffected mirror side did not differ
from controls. However in two of the ten patients we
studied, C-fiber-related laser evoked potentials were absent
after stimulating the unaffected side and both patients
had mild epidermal fiber loss, though less severe in the
unaffected than in the affected side. This finding is in line
with previous clinical, neurophysiological and skin biopsy
studies showing bilateral nerve fiber damage and supports the
hypothesis that PHN may occasionally cause mild, subclinical
sensory afferent pathway involvement in the unaffected side
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(Haanpää et al., 1997; Oaklander et al., 1998; Truini et al.,
2008).
Our skin biopsy study showing that ophthalmic PHN
differentially affects epidermal and dermal myelinated fibers and
spares the autonomic skin innervation provides new information
for understanding the mechanisms underlying this disabling
condition.
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